Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial

Franco Citterio, M Klinger, Š Vítko, M Glyda, K Midtvedt, S Stefoni, F Pietruck, J Squifflet, G Segoloni, B Krüger, H Sperschneider, B Banas, L Bäckman, M Weber, M Carmellini, F Perner, K Claesson, W Marcinkowski, M Ostrowski, G SenatorskiJ Nordström, K. Salmela

Risultato della ricerca: Contributo in rivistaArticolo in rivista

36 Citazioni (Scopus)

Abstract

Long-term use of corticosteroids is associated with considerable morbidity, including cardiovascular and metabolic adverse effects.
Lingua originaleEnglish
pagine (da-a)492-498
Numero di pagine7
RivistaTransplantation
Volume94
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Acute Disease
  • Adrenal Cortex Hormones
  • Adult
  • Antibodies, Monoclonal
  • Biopsy
  • Chi-Square Distribution
  • Chronic Disease
  • Drug Therapy, Combination
  • Europe
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Graft Survival
  • Humans
  • Immunosuppressive Agents
  • Kaplan-Meier Estimate
  • Kidney Function Tests
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Mycophenolic Acid
  • Recombinant Fusion Proteins
  • Risk Assessment
  • Risk Factors
  • Tacrolimus
  • Time Factors
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial'. Insieme formano una fingerprint unica.

Cita questo